Authors:
Venables, K
Winfield, E
Deighton, A
Aird, E
Hoskin, P
Citation: K. Venables et al., A survey of radiotherapy quality control practice in the United Kingdom for the START trial, RADIOTH ONC, 60(3), 2001, pp. 311-318
Authors:
Venables, K
Winfield, E
Deighton, A
Aird, E
Hoskin, P
Citation: K. Venables et al., The START Trial - measurements in semi-anatomical breast and chest wall phantoms, PHYS MED BI, 46(7), 2001, pp. 1937-1948
Authors:
Mainwaring, PN
Cunningham, D
Gregory, W
Hoskin, P
Hancock, B
Norton, AJ
MacLennan, K
Smith, P
Hudson, GV
Linch, D
Citation: Pn. Mainwaring et al., Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen forpatients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdfiaCEBO versus PMitCEBO, BLOOD, 97(10), 2001, pp. 2991-2997
Authors:
Bentzen, SM
Hoskin, P
Roos, D
Nielsen, OS
Citation: Sm. Bentzen et al., Fractionated radiotherapy for metastatic bone pain: Evidence-based medicine or ...?, INT J RAD O, 46(3), 2000, pp. 681-682
Citation: P. Hoskin, Catalogue of seals in the National-Museum-of-Wales, Vol 2: Ecclesiastical,monastic and collegiate seals with a supplement concerning Wales, J ECCL HIST, 51(1), 2000, pp. 137-138
Authors:
Schersten, A
Areback, H
Cornell, D
Hoskin, P
Aberg, A
Armstrong, R
Citation: A. Schersten et al., Dating mafic-ultramafic intrusions by ion-microprobing contact-melt zircon: examples from SW Sweden, CONTR MIN P, 139(1), 2000, pp. 115-125
Authors:
Shah, N
Hoskin, P
McMillan, A
Gibson, P
Lowe, J
Wong, WL
Citation: N. Shah et al., The impact of FDG positron emission tomography imaging on the management of lymphomas, BR J RADIOL, 73(869), 2000, pp. 482-487
Authors:
Shah, N
Groom, N
Jackson, S
Sibtain, A
Hoskin, P
Citation: N. Shah et al., A pilot study to assess the feasibility of prior scalp cooling with palliative whole brain radiotherapy, BR J RADIOL, 73(869), 2000, pp. 514-516
Authors:
Glynne-Jones, R
Saunders, MI
Hoskin, P
Phillips, H
Citation: R. Glynne-jones et al., A pilot study of continuous, hyperfractionated, accelerated radiotherapy in rectal adenocarcinoma, CL ONCOL-UK, 11(5), 1999, pp. 334-339
Authors:
Ashton, A
Balyckyi, J
Barton, R
Bolger, J
Cruickshank, C
Davidson, J
Dearnaley, D
Elyan, S
Harmer, C
Hoskin, P
Jose, C
Maitland, L
Melville, P
Meyer, L
Neal, A
Regan, J
Skeet, O
Skelton, L
Tait, D
Wardle, J
Wynne, C
Yarnold, J
Citation: A. Ashton et al., 8 Gy single fraction radiotherapy for the treatment of metastatic skeletalpain: randomised comparison with a multifraction schedule over 12 months of patient follow-up, RADIOTH ONC, 52(2), 1999, pp. 111-121
Authors:
Goodchild, K
Hoskin, P
Dische, S
Pigott, K
Powell, M
Saunders, M
Citation: K. Goodchild et al., A feasibility study of continuous hyperfractionated accelerated radiotherapy (CHART) and brachytherapy in patients with early oral or oropharyngeal carcinomas, RADIOTH ONC, 50(1), 1999, pp. 29-31
Authors:
Harrison, CN
Gregory, W
Hudson, GV
Devereux, S
Goldstone, AH
Hancock, B
Winfield, D
MacMillan, AK
Hoskin, P
Newland, AC
Milligan, D
Linch, DC
Citation: Cn. Harrison et al., High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML, BR J CANC, 81(3), 1999, pp. 476-483